產(chǎn)品詳情
簡單介紹：
Anti-C12ORF50抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C12ORF50抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C12ORF50
Cat. Number:
Anti-C12ORF50抗體KL-9950R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Encoding over 1,100 genes within 132 million bases, chromosome 12 makes up about 4.5% of the human genome. A number of skeletal deformities are linked to chromosome 12 including hypochondrogenesis, Anti-C12ORF50抗體achondrogenesis and Kniest dysplasia. Noonan syndrome, which includes heart and facial developmental defects among the primary symptoms, is caused by a mutant form of PTPN11 gene product, SH-PTP2. Chromosome 12 is also home to a homeobox gene cluster which encodes crucial transcription factors for morphogenesis, and the natural killer complex gene cluster encoding C-type lectin proteins which mediate the NK cell response to MHC I interaction. Trisomy 12p leads to facial development defects, seizure disorders and a host of other symptoms varying in severity depending on the extent of mosaicism and is most severe in cases of complete trisomy. The C12orf50 gene product has been provisionally designated C12orf50 pending further characterization.
Also known as:
C5H12orf50; ChromosomeAnti-C12ORF50抗體 12 open reading frame 50; chromosome 12 open reading frame 50 ortholog; Hypothetical protein LOC160419; CL050_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C12ORF50.
●
Predicted Molecular Anti-C12ORF50抗體Weight: 47kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working Anti-C12ORF50抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-C12ORF50抗體dilutions must be determined by the end user.
kl089Mu02 單核細(xì)胞趨化蛋白3(MCP3)多克隆抗體 Polyclonal Antibody to Monocyte Chemotactic Protein 3 (MCP3)
kl090Mu02 巨噬細(xì)胞集落刺激因子(MCSF)多克隆抗體 Polyclonal Antibody to Colony Stimulating Factor 1, Macrophage (MCSF)
kl091Mu02 巨噬細(xì)胞來源趨化因子(MDC)多克隆抗體 Polyclonal Antibody to Macrophage Derived Chemokine (MDC)
kl092Mu02 巨噬細(xì)胞炎性蛋白1α(MIP1α)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 1 Alpha (MIP1a)
kl093Mu02 巨噬細(xì)胞炎性蛋白1β(MIP1β)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 1 Beta (MIP1b)
kl095Mu02 巨噬細(xì)胞炎性蛋白3α(MIP3α)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 3 Alpha (MIP3a)
kl096Mu02 巨噬細(xì)胞炎性蛋白3β(MIP3β)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 3 Beta (MIP3b)
kl097Mu02 基質(zhì)金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl098Mu02 基質(zhì)金屬蛋白酶10(MMP10)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 10 (MMP10)
kl100Eq01 基質(zhì)金屬蛋白酶2(MMP2)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 2 (MMP2)
kl100Mu02 基質(zhì)金屬蛋白酶2(MMP2)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 2 (MMP2)
kl100Po01 基質(zhì)金屬蛋白酶2(MMP2)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 2 (MMP2)
kl101Mu02 基質(zhì)金屬蛋白酶3(MMP3)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 3 (MMP3)
kl102Mu02 基質(zhì)金屬蛋白酶7(MMP7)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)
kl103Mu02 基質(zhì)金屬蛋白酶8(MMP8)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)
kl104Mu02 膽囊收縮素A受體(CCKAR)多克隆抗體 Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl105Mu02 神經(jīng)生長因子(NGF)多克隆抗體 Polyclonal Antibody to Nerve Growth Factor (NGF)
